Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans

CONTEXT: In 2005, HEDIS introduced a quality measure to assess the receipt of disease modifying anti-rheumatic drugs (DMARDs) among patients with rheumatoid arthritis (RA). OBJECTIVE: To identify sociodemographic, community, and health-plan factors associated with DMARD receipt among Medicare manage...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Schmajuk, Gabriela, Trivedi, Amal, Solomon, Daniel, Yelin, Edward, Trupin, Laura, Chakravarty, Eliza, Yazdany, Jinoos
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3172813/
https://ncbi.nlm.nih.gov/pubmed/21285425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2011.67
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky